Guardian Pharmacy Services, Inc.
GRDN
$38.87
$1.784.80%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.46B | 1.46B | 1.45B | 1.39B | 1.33B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.46B | 1.46B | 1.45B | 1.39B | 1.33B |
| Cost of Revenue | 1.15B | 1.15B | 1.16B | 1.12B | 1.07B |
| Gross Profit | 316.58M | 304.68M | 292.72M | 274.32M | 260.48M |
| SG&A Expenses | 231.19M | 217.47M | 213.09M | 214.34M | 321.73M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.38B | 1.37B | 1.37B | 1.33B | 1.39B |
| Operating Income | 85.39M | 87.21M | 79.63M | 59.98M | -61.25M |
| Income Before Tax | 95.82M | 78.61M | 73.42M | 58.55M | -63.73M |
| Income Tax Expenses | 29.29M | 25.38M | 24.47M | 19.01M | 12.15M |
| Earnings from Continuing Operations | 66.52 | 53.23 | 48.96 | 39.53 | -75.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -615.00K | -163.00K | 261.00K | 705.00K | -6.34M |
| Net Income | 65.91M | 53.07M | 49.22M | 40.24M | -82.22M |
| EBIT | 85.39M | 87.21M | 79.63M | 59.98M | -61.25M |
| EBITDA | 108.75M | 110.25M | 101.96M | 81.73M | -40.35M |
| EPS Basic | 1.04 | 0.84 | 0.79 | 0.28 | -1.72 |
| Normalized Basic EPS | 0.94 | 0.88 | 0.81 | 0.61 | -0.75 |
| EPS Diluted | 1.04 | 0.84 | 0.78 | 0.27 | -1.72 |
| Normalized Diluted EPS | 0.93 | 0.87 | 0.80 | 0.60 | -0.76 |
| Average Basic Shares Outstanding | 252.09M | 250.81M | 249.53M | 248.26M | 247.28M |
| Average Diluted Shares Outstanding | 254.58M | 253.95M | 253.17M | 252.27M | 249.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -14.97% |